{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"severe-combined-immunodeficiency-due-to-cd70-deficiency","columns":[{"gene":"","key":"population-e65a00414e45e876b3f0","label":"Lymphoproliferative syndrome 3","mondoId":"MONDO:0034054","onsetQualifier":null,"originColumnKey":"MONDO:0034054/OMIM:618261","originalViews":[{"key":"MONDO:0034054/OMIM:618261","label":"Lymphoproliferative syndrome 3","scopeLabel":"OMIM:618261","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["37aa7dbe032719637e515300372ec9cc7d428da6c18d4fb5658cfe2b10e3979d","5fa54d43bc768da5e3eb3dca8f188edbde343519856514dd86e4751719001a59","907859fe92c3d7dfed62acb84912bcf806946c4a7e1ec2ac8711436885b42ed5","96a7c089f94cecc81e59f5f443f3bd7753d19d2fd6282ba848ab65b97d6d0762","be61fba81ca5a7b00a131b0bed915349aa452924902ecb9e435bc77846e97d7b","c12fb9a5dfb7e9d187d35dd5b4d277fc14a53bb815a8a5ff3cfed58632966fb2","cb7901b85331865a981d8b192ba2547be078c43f2d6eb3ad3aa4821ef7a5ad9c","eac05d0a597dbac5129845aed13d4b2b1f36ee3110c4846d20a67a190ad9a278","ee6ea6d66a5c4e269d5c335c1c3fa873a456291499d03e52154782f87744e47c","f7ef427670ff3687a1a971877565db528e3b6006634a9c0332b29fce8f1137b5"],"recordQualifiers":{},"scopeLabel":"OMIM:618261","sourceIds":["OMIM:618261"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-e65a00414e45e876b3f0"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0004313","HP:0001433","HP:0012189","HP:0002716","HP:0005523","HP:0410297","HP:0001954"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":9,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":10,"sourceGroups":{"published":10}},"features":[{"hpoId":"HP:0004313","label":"Decreased circulating immunoglobulin concentration","primary":true},{"hpoId":"HP:0001433","label":"Hepatosplenomegaly","primary":true},{"hpoId":"HP:0012189","label":"Hodgkin lymphoma","primary":true},{"hpoId":"HP:0002716","label":"Lymphadenopathy","primary":true},{"hpoId":"HP:0005523","label":"Lymphoproliferative disorder","primary":true},{"hpoId":"HP:0410297","label":"Partial absence of specific antibody response to tetanus vaccine","primary":true},{"hpoId":"HP:0001954","label":"Recurrent fever","primary":true},{"hpoId":"HP:0002719","label":"Recurrent infections","primary":false},{"hpoId":"HP:0040218","label":"Reduced total natural killer cell count","primary":false},{"hpoId":"HP:0032170","label":"Severe varicella zoster infection","primary":false}],"ledeHtml":"A rare autosomal recessive primary immunodeficiency characterized by susceptibility to Epstein-Barr virus (EBV)-related disorders (B-cell lymphoproliferative disorders including Hodgkin lymphoma) as well as dysgammaglobulinemia and recurrent infections. Patients can present with recurrent fever, lymphadenopathy, hepatosplenomegaly, Behçet-like stomatitis, pharyngitis, tonsillitis, adenitis, and viral encephalitis.","mondoId":"MONDO:0034054","node":{"canonicalSlug":"severe-combined-immunodeficiency-due-to-cd70-deficiency","comparisons":[{"documentSha256":"57e801349edcc2bd33a6aba51ad1050249b354b06f04c98301aa0dd7b8c3a20b","key":"legacy-severe-combined-immunodeficiency-due-to-cd70-deficiency","kind":"legacy","label":"severe combined immunodeficiency due to CD70 deficiency","memberIds":["MONDO:0034054"],"mondoId":"MONDO:0034054","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/severe-combined-immunodeficiency-due-to-cd70-deficiency.57e801349edcc2bd33a6aba51ad1050249b354b06f04c98301aa0dd7b8c3a20b.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Severe combined immunodeficiency due to CD70 deficiency","originalSourceId":"ORPHA:538958","paragraphs":["A rare autosomal recessive primary immunodeficiency characterized by susceptibility to Epstein-Barr virus (EBV)-related disorders (B-cell lymphoproliferative disorders including Hodgkin lymphoma) as well as dysgammaglobulinemia and recurrent infections. Patients can present with recurrent fever, lymphadenopathy, hepatosplenomegaly, Behçet-like stomatitis, pharyngitis, tonsillitis, adenitis, and viral encephalitis."],"rawAttribution":"ORPHA:538958","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:03:08Z","upstream":"ORPHA:538958","url":"https://rarediseases.info.nih.gov/diseases/17978"},"ownColumnKeys":["population-e65a00414e45e876b3f0"],"publication":"published","relationships":[{"kind":"parent","label":"severe combined immunodeficiency","mondoId":"MONDO:0015974","slug":"severe-combined-immunodeficiency"},{"kind":"parent","label":"lymphoproliferative syndrome","mondoId":"MONDO:0016537","slug":"lymphoproliferative"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"37aa7dbe032719637e515300372ec9cc7d428da6c18d4fb5658cfe2b10e3979d","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:618261","disease_name":"Lymphoproliferative syndrome 3","evidence":"PCS","frequency_raw":"3/4","hpo_id":"HP:0004313","is_excluded":false,"label":"Decreased circulating immunoglobulin concentration","onset_id":null,"reference":"PMID:28011864","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"5fa54d43bc768da5e3eb3dca8f188edbde343519856514dd86e4751719001a59","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:618261","disease_name":"Lymphoproliferative syndrome 3","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0032170","is_excluded":false,"label":"Severe varicella zoster infection","onset_id":null,"reference":"PMID:28011864","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"907859fe92c3d7dfed62acb84912bcf806946c4a7e1ec2ac8711436885b42ed5","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:618261","disease_name":"Lymphoproliferative syndrome 3","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001433","is_excluded":false,"label":"Hepatosplenomegaly","onset_id":null,"reference":"PMID:28011863","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"96a7c089f94cecc81e59f5f443f3bd7753d19d2fd6282ba848ab65b97d6d0762","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:618261","disease_name":"Lymphoproliferative syndrome 3","evidence":"PCS","frequency_raw":"11/11","hpo_id":"HP:0002716","is_excluded":false,"label":"Lymphadenopathy","onset_id":null,"reference":"PMID:28011863;PMID:28011864","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"be61fba81ca5a7b00a131b0bed915349aa452924902ecb9e435bc77846e97d7b","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:618261","disease_name":"Lymphoproliferative syndrome 3","evidence":"PCS","frequency_raw":"2/4","hpo_id":"HP:0002719","is_excluded":false,"label":"Recurrent infections","onset_id":null,"reference":"PMID:28011864","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c12fb9a5dfb7e9d187d35dd5b4d277fc14a53bb815a8a5ff3cfed58632966fb2","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:618261","disease_name":"Lymphoproliferative syndrome 3","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0040218","is_excluded":false,"label":"Reduced total natural killer cell count","onset_id":null,"reference":"PMID:28011863","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"cb7901b85331865a981d8b192ba2547be078c43f2d6eb3ad3aa4821ef7a5ad9c","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:618261","disease_name":"Lymphoproliferative syndrome 3","evidence":"PCS","frequency_raw":"4/5","hpo_id":"HP:0012189","is_excluded":false,"label":"Hodgkin lymphoma","onset_id":null,"reference":"PMID:28011863;PMID:28011864","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"eac05d0a597dbac5129845aed13d4b2b1f36ee3110c4846d20a67a190ad9a278","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:618261","disease_name":"Lymphoproliferative syndrome 3","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0410297","is_excluded":false,"label":"Partial absence of specific antibody response to tetanus vaccine","onset_id":null,"reference":"PMID:28011864","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"ee6ea6d66a5c4e269d5c335c1c3fa873a456291499d03e52154782f87744e47c","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:618261","disease_name":"Lymphoproliferative syndrome 3","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0005523","is_excluded":false,"label":"Lymphoproliferative disorder","onset_id":null,"reference":"PMID:28011864","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f7ef427670ff3687a1a971877565db528e3b6006634a9c0332b29fce8f1137b5","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:618261","disease_name":"Lymphoproliferative syndrome 3","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001954","is_excluded":false,"label":"Recurrent fever","onset_id":null,"reference":"PMID:28011863","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17978\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:538958</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare autosomal recessive primary immunodeficiency characterized by susceptibility to Epstein-Barr virus (EBV)-related disorders (B-cell lymphoproliferative disorders including Hodgkin lymphoma) as well as dysgammaglobulinemia and recurrent infections. Patients can present with recurrent fever, lymphadenopathy, hepatosplenomegaly, Behçet-like stomatitis, pharyngitis, tonsillitis, adenitis, and viral encephalitis.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17978\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"severe-combined-immunodeficiency-due-to-cd70-deficiency","sourceDocuments":[{"name":"GARD: Severe combined immunodeficiency due to CD70 deficiency","reviewed":null,"source_release":"2026-10-21T17:03:08Z","url":"https://rarediseases.info.nih.gov/diseases/17978"}],"sourceNote":"","synonyms":["lymphoproliferative syndrome 3"],"takeawayHtml":"","title":"severe combined immunodeficiency due to CD70 deficiency"},"schemaVersion":1}
